NPBWR1 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P48145 |
---|---|
Clone Names | 100406016 |
Gene ID | 2831 |
---|---|
Other Names | Neuropeptides B/W receptor type 1, G-protein coupled receptor 7, NPBWR1, GPR7 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NPBWR1 |
---|---|
Synonyms | GPR7 |
Function | Interacts specifically with a number of opioid ligands. Receptor for neuropeptides B and W, which may be involved in neuroendocrine system regulation, food intake and the organization of other signals. Has a higher affinity for neuropeptide B. |
Cellular Location | Cell membrane; Multi-pass membrane protein. |
Tissue Location | Found in cerebellum and frontal cortex. Detected at high levels in hippocampus, amygdala and trachea; at moderate levels in fetal brain, pituitary gland and prostate. Not in caudate, accumbens, kidney or liver. Also detected at high levels in lung carcinoma |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
NPBWR1 interacts specifically with a number of opioid ligands. Receptor for neuropeptides B and W, which may be involved in neuroendocrine system regulation, food intake and the organization of other signals. Has a higher affinity for neuropeptide B.
References
Luttrell, L.M. Mol. Biotechnol. 39(3):239-264(2008)Lambert, N.A. Sci Signal 1 (25), RE5 (2008) :Cottrell, S., et al. J. Urol. 177(5):1753-1758(2007)Mazzocchi, G., et al. J. Clin. Endocrinol. Metab. 90(6):3466-3471(2005)Zaratin, P.F., et al. Mol. Cell. Neurosci. 28(1):55-63(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.